A comprehensive review on liver targeting: emphasis on nanotechnology-based molecular targets and receptors mediated approaches
AK Mishra, M Pandey, HK Dewangan, N Sl… - Current Drug …, 2022 - ingentaconnect.com
Background: The pathogenesis of hepatic diseases involves several cells, which
complicates the delivery of pharmaceutical agents. Many severe liver diseases affecting the …
complicates the delivery of pharmaceutical agents. Many severe liver diseases affecting the …
[HTML][HTML] High-density lipoprotein remodeling by phospholipid nanoparticles improves cholesterol efflux capacity and protects from atherosclerosis
VA Kudinov, TI Torkhovskaya, TS Zakharova… - Biomedicine & …, 2021 - Elsevier
The efficiency of cholesterol efflux from cells promoted by high-density lipoproteins (HDLs)
depends on HDL concentration and functional properties. The term “dysfunctional HDL” …
depends on HDL concentration and functional properties. The term “dysfunctional HDL” …
Pharmacological targets for correction of dyslipidemias. Opportunities and prospects of therapeutic use
VA Kudinov, TS Zakharova, TI Torkhovskaya… - … ), Supplement Series B …, 2018 - Springer
The review summarizes literature data on existing pharmacological agents and novel drug
preparations developed for correction of dyslipidemias and molecular mechanisms of their …
preparations developed for correction of dyslipidemias and molecular mechanisms of their …
Investigation of Nanodrug Phospholipovit by Small-Angle Neutron Scattering
MA Kiselev, DN Selyakov, IV Gapon, AI Ivankov… - Crystallography …, 2019 - Springer
The structure of aqueous solutions of the Phospholipovit medicine, intended for transport of
water-insoluble molecular drugs, has been investigated by small-angle neutron scattering …
water-insoluble molecular drugs, has been investigated by small-angle neutron scattering …